175 related articles for article (PubMed ID: 34160470)
1. Prognostic value of inflammatory and nutritional markers for hepatocellular carcinoma.
Xu Y; Yuan X; Zhang X; Hu W; Wang Z; Yao L; Zong L
Medicine (Baltimore); 2021 Jun; 100(25):e26506. PubMed ID: 34160470
[TBL] [Abstract][Full Text] [Related]
2. Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101.
He CB; Lin XJ
PLoS One; 2017; 12(3):e0174769. PubMed ID: 28355305
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
[TBL] [Abstract][Full Text] [Related]
4. Are inflammation-based markers useful in patients with hepatocellular carcinoma and clinically significant portal hypertension after liver resection?
Qin L; Li C; Xie F; Wang Z; Wen T
Biosci Trends; 2020 Sep; 14(4):297-303. PubMed ID: 32641640
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Inflammatory and Nutritional Markers for Patients With Early-Stage Poorly-to Moderately-Differentiated Cervical Squamous Cell Carcinoma.
Guo J; Lv W; Wang Z; Shang Y; Yang F; Zhang X; Xiao K; Zhang S; Pan X; Han Y; Zong L; Hu W
Cancer Control; 2023; 30():10732748221148913. PubMed ID: 36599103
[TBL] [Abstract][Full Text] [Related]
6. Can Hematological Inflammatory Parameters Predict Mortality in Hepatocellular Carcinoma?
Dertli R; Asil M; Biyik M; Karakarcayildiz A; Keskin M; Göktepe HM; Kayar Y; Ataseven H
J Gastrointest Cancer; 2021 Jun; 52(2):666-675. PubMed ID: 32617832
[TBL] [Abstract][Full Text] [Related]
7. The effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma.
Sellers CM; Uhlig J; Ludwig JM; Pollak JS; Taddei TH; Stein SM; Lim JK; Kim HS
Cancer Med; 2021 Aug; 10(16):5395-5404. PubMed ID: 34318618
[TBL] [Abstract][Full Text] [Related]
8. A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI).
Ji F; Liang Y; Fu SJ; Guo ZY; Shu M; Shen SL; Li SQ; Peng BG; Liang LJ; Hua YP
BMC Cancer; 2016 Feb; 16():137. PubMed ID: 26907597
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of inflammation markers in postoperative gliomas with or without adjuvant treatments.
Luo Y; Deng R; Zhong Q; Luo D; Li X; Chen X; Tao S; Feng Z; Jiayi L; Huang Y; Li J; Liu W
Medicine (Baltimore); 2021 Jun; 100(25):e26437. PubMed ID: 34160435
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of tumor response in hepatocellular carcinoma after DEB-TACE.
Schobert IT; Savic LJ; Chapiro J; Bousabarah K; Chen E; Laage-Gaupp F; Tefera J; Nezami N; Lin M; Pollak J; Schlachter T
Eur Radiol; 2020 Oct; 30(10):5663-5673. PubMed ID: 32424595
[TBL] [Abstract][Full Text] [Related]
11. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
Deng M; Ma X; Liang X; Zhu C; Wang M
Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of Pre-Operative Platelet to Lymphocyte Ratio in Patients with Resected Primary Hepatocellular Carcinoma.
Dong L; Bai K; Cao Y; Huang Q; Lv L; Jiang Y
Clin Lab; 2016 Nov; 62(11):2191-2196. PubMed ID: 28164677
[TBL] [Abstract][Full Text] [Related]
13. Validation of inflammation-based prognostic models in patients with hepatitis B-associated hepatocellular carcinoma: a retrospective observational study.
Pang Q; Zhou L; Qu K; Cui RX; Jin H; Liu HC
Eur J Gastroenterol Hepatol; 2018 Jan; 30(1):60-70. PubMed ID: 29189392
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of the neutrophil-to-lymphocyte ratio for hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis.
Li SH; Wang QX; Yang ZY; Jiang W; Li C; Sun P; Wei W; Shi M; Guo RP
World J Gastroenterol; 2017 May; 23(17):3122-3132. PubMed ID: 28533669
[TBL] [Abstract][Full Text] [Related]
15. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and prognostic nutrition index as preoperative predictors of early mortality after liver resection for huge (≥10 cm) hepatocellular carcinoma.
Goh BK; Kam JH; Lee SY; Chan CY; Allen JC; Jeyaraj P; Cheow PC; Chow PK; Ooi LL; Chung AY
J Surg Oncol; 2016 May; 113(6):621-7. PubMed ID: 26861568
[TBL] [Abstract][Full Text] [Related]
16. Preoperative albumin-bilirubin grade plus platelet-to-lymphocyte ratio predict the outcomes of patients with BCLC stage A hepatocellular carcinoma after liver resection.
Li C; Zhang XY; Peng W; Wen TF; Yan LN; Li B; Yang JY; Wang WT; Xu MQ; Chen LP
Medicine (Baltimore); 2018 Jul; 97(29):e11599. PubMed ID: 30024565
[TBL] [Abstract][Full Text] [Related]
17. [The Predictive Value of Perioperative Inflammatory Indicatorsin Prognosis of the Intrahepatic Cholangiocarcinoma Patients after Hepatectomy].
Zhang ZF; Wang T; Kong JJ; Yang LP; Yang XW; Wang WT
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):403-410. PubMed ID: 32543151
[TBL] [Abstract][Full Text] [Related]
18. A Novel Inflammation-Based Prognostic Score: The Fibrinogen/Albumin Ratio Predicts Prognoses of Patients after Curative Resection for Hepatocellular Carcinoma.
Xu Q; Yan Y; Gu S; Mao K; Zhang J; Huang P; Zhou Z; Chen Z; Zheng S; Liang J; Lin Z; Wang J; Yan J; Xiao Z
J Immunol Res; 2018; 2018():4925498. PubMed ID: 30027102
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of inflammation-based indices in patients with resected hepatocellular carcinoma.
Kong W; Yang M; Zhang J; Cheng Y; Dai T; Zhang J; Wang G; Zhang J
BMC Cancer; 2021 Apr; 21(1):469. PubMed ID: 33906632
[TBL] [Abstract][Full Text] [Related]
20. Intermediate stage hepatocellular carcinoma: Comparison of the value of inflammation-based scores in predicting progression-free survival of patients receiving transarterial chemoembolization.
Liu Y; Shi M; Chen S; Wan W; Shen L; Shen B; Qi H; Cao F; Wu Y; Huang T; Chen G; Mo J; Ye D; Zhang Y; Feng Z; Fan W
J Cancer Res Ther; 2021 Jul; 17(3):740-748. PubMed ID: 34269308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
